Streetbeat News

Stock Prices

LULU

PTON

Lululemon Athletica Inc (LULU) has announced a five-year strategic partnership with Peloton Interactive Inc (PTON). Under the partnership, PTON will become the exclusive digital fitness content provider for LULU, and LULU will become the primary athletic apparel partner to PTON. The partnership is seen as a positive move by Raymond James analyst Rick B. Patel, who believes it will help LULU extract value from its MIRROR acquisition, which it took a $442.7 million impairment for in 4Q22.

Portfolio Pulse from Shivani Kumaresan

September 28, 2023 | 6:45 pm

SSYS

Stratasys has terminated its merger agreement with Desktop Metal and is exploring strategic alternatives. This has led to an increase in Stratasys' share price.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 6:45 pm

CURLF

MSOS

Curaleaf's Executive Chairman, Boris Jordan, has announced that by uplisting to the TSX, the company can start engaging with large scale institutional investors.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 6:33 pm

CURLF

MSOS

Curaleaf's Executive Chairman, Boris Jordan, has stated that the company's current focus is to ensure their cannabis flower product is as good, if not better, than any other on the market.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 6:32 pm

ACN

ASTI

BCLI

BNOX

BXRX

CHS

RNLX

U.S. stocks traded higher with the Dow Jones gaining over 100 points and the NASDAQ rising 0.95%. Accenture's shares fell more than 4% after reporting mixed Q4 results and weak FY24 adjusted EPS guidance. Bionomics, Baudax Bio, and Chico's FAS saw their shares rise significantly due to positive trial results, FDA designation, and acquisition news respectively. Ascent Solar Technologies, Brainstorm Cell Therapeutics, and Renalytix saw their shares drop due to public offering pricing, negative FDA Advisory Committee vote, and weak sales and guidance respectively.

Portfolio Pulse from Lisa Levin

September 28, 2023 | 6:30 pm

NVO

Novo Nordisk (NYSE:NVO) has outperformed the market over the past 10 years, producing an average annual return of 18.54%. If an investor had bought $100 of NVO stock 10 years ago, it would be worth $544.33 today. The company currently has a market capitalization of $409.70 billion.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 6:30 pm

IBN

ICICI Bank (NYSE:IBN) has outperformed the market over the past 10 years by 5.24% on an annualized basis, producing an average annual return of 14.99%. If an investor had bought $1000 of IBN stock 10 years ago, it would be worth $4,023.55 today.

Portfolio Pulse from Benzinga Insights

September 28, 2023 | 6:30 pm

ASND

BBIO

BMRN

Raymond James initiated coverage on BioMarin Pharmaceuticals Inc (BMRN) with a Market Perform rating, citing a lack of near-term growth drivers. The analysts highlighted the launch of Roctavian and Voxzogo as key growth drivers, but expressed concerns about Voxzogo's long-term outlook due to advancing competitive treatments from BridgeBio Pharma Inc (BBIO) and Ascendis Pharma A/S (ASND). BioMarin's shares are expected to remain under pressure until BBIO reports 12-month data.

Portfolio Pulse from Vandana Singh

September 28, 2023 | 6:29 pm

CERE

Piper Sandler has initiated coverage on Cerevel Therapeutics with an Overweight rating and a price target of $33. This has led to an increase in the trading of Cerevel Therapeutics shares.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 6:28 pm

FUL

H.B. Fuller's shares are trading higher despite the company missing its Q3 expectations and providing soft guidance for the future.

Portfolio Pulse from Benzinga Newsdesk

September 28, 2023 | 6:25 pm